ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 89 filers reported holding ERASCA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $465,385 | -28.6% | 236,236 | 0.0% | 0.06% | -26.8% |
| Q2 2023 | $652,011 | -8.3% | 236,236 | 0.0% | 0.08% | -37.9% |
| Q1 2023 | $711,070 | -64.4% | 236,236 | -49.0% | 0.13% | -65.1% |
| Q4 2022 | $1,995,409 | -45.9% | 462,972 | -2.0% | 0.38% | -49.4% |
| Q3 2022 | $3,685,000 | -27.4% | 472,472 | -48.1% | 0.75% | -26.5% |
| Q2 2022 | $5,075,000 | – | 911,168 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |